drugset / Trial / NCT02962076
Study of Cardiac PET/CT Imaging to Guide Ablation Treatment of Ventricular Tachycardia
Phase 0
Terminated
11 enrolled
Khaled Awad, MD
Biosense Webster, Inc. · collabWashington University School of Medicine · collab
NaSingle-groupOpen-labelDiagnostic
Summary
Imaging is to be performed prior to procedure using positron emission tomography/ computed tomography (PET/CT), after a special dye is injected. The scans are going to be merged with other cardiac scans when doing the ablation procedure to correlate anatomy with physiology.
Timeline
- Start
- 2020-09-21
- Primary completion
- 2023-03-01
- Completion
- 2024-10-31
Outcome
Outcome not reported
Stopped (Enrollment): “Investigator departing institution and enrollment not met.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meta-hydroxyephedrine | Unknown | — | — |